INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 155 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,517,000 | +3943.7% | 277,359 | +2519.8% | 0.03% | +3000.0% |
| Q1 2021 | $359,000 | -58.3% | 10,587 | -81.1% | 0.00% | -85.7% |
| Q1 2020 | $860,000 | -12.6% | 55,926 | +95.0% | 0.01% | +133.3% |
| Q4 2019 | $984,000 | -33.8% | 28,680 | -85.6% | 0.00% | -40.0% |
| Q3 2019 | $1,487,000 | -49.5% | 199,020 | -12.2% | 0.01% | -50.0% |
| Q2 2019 | $2,942,000 | -17.1% | 226,693 | -22.2% | 0.01% | -16.7% |
| Q1 2019 | $3,548,000 | +61.7% | 291,334 | +51.2% | 0.01% | +33.3% |
| Q4 2018 | $2,194,000 | +8.2% | 192,653 | +100.1% | 0.01% | +28.6% |
| Q1 2018 | $2,027,000 | -10.9% | 96,274 | -38.7% | 0.01% | 0.0% |
| Q4 2017 | $2,274,000 | +354.8% | 157,074 | +649.9% | 0.01% | +250.0% |
| Q1 2015 | $500,000 | – | 20,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |